TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2012

Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors.

Jessica H Brehm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.